Overview of Chromosomal Disorders

Human chromosomes are linear structures in human cells that carry genetic information. Humans have 23 pairs of chromosomes, of which 22 pairs are autosomes and one pair are sex chromosomes. Autosomes determine the general characteristics of humans, while sex chromosomes determine the sex of humans. The karyotype of a chromosome is the phenotype of the chromosome group in the metaphase of cell division, which is the sum of the number, size, and morphological characteristics of the chromosomes. Karyotype analysis is a method to detect chromosomal abnormalities that can be used for the diagnosis of genetic diseases or tumors. The morphological characteristics of chromosomes mainly include the position of the centromere and the length of the chromatid. According to the position of the centromere, chromosomes can be divided into three types: metacentric chromosomes, with the centromere located at 1/2~5/8 of the chromosome axis, and the two arms are similar in length; submetacentric chromosomes, with the centromere clearly deviating from the center, located at 5/8~7/8 of the chromosome axis, and the two arms are different in length; and acrocentric chromosomes, with the centromere close to one end, located at 7/8~end of the chromosome axis, and the short arm is very short.

Chromosomal Abnormalities/ Chromosomal Disorders

Chromosomal disorders refer to abnormalities in the number or structure of chromosomes, resulting in disruption of the genomic balance and affecting the normal function and expression of cells. Chromosomal disorders are important causes of congenital malformations, intellectual disabilities, infertility, miscarriage, and cancer. It is estimated that about 0.5% of newborns have chromosomal disorders at birth. Chromosomal disorders can be divided into two major categories: numerical and structural. Numerical disorders are those in which the total number of chromosomes differs from that of normal people, such as trisomy syndromes, Turner syndrome, Klinefelter syndrome, and others. Structural disorders are those in which the morphology of chromosomes changes, such as deletion, duplication, translocation, inversion, ring, and so on. The main mechanism of chromosomal disorders is aneuploidy, which means that homologous chromosomes or sister chromatids fail to separate correctly during meiosis or mitosis, resulting in an uneven number or structure of chromosomes in daughter cells.

Trisomy Syndromes

Trisomy syndromes are a group of chromosomal disorders caused by the presence of an extra copy of a specific chromosome, resulting in 47 chromosomes instead of the normal 46. Trisomy syndromes can affect any chromosome, but most of them are incompatible with life and cause early miscarriage. The most common trisomy syndromes that survive to term are trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome). These syndromes are associated with various physical and mental abnormalities, depending on which chromosome is affected and how much extra genetic material is expressed.

Trisomy 21 (Down syndrome) is the most common and well-known trisomy syndrome, affecting about 1 in 700 live births. It is caused by the presence of an extra copy of chromosome 21, which contains about 300 genes. People with Down syndrome have characteristic facial features, such as a flat nasal bridge, almond-shaped eyes, small ears and mouth, and a protruding tongue. They also have various physical problems, such as congenital heart defects, gastrointestinal anomalies, hypotonia (low muscle tone), short stature, and increased susceptibility to infections. Moreover, they have intellectual disabilities ranging from mild to moderate, as well as behavioral and emotional difficulties. The diagnosis of Down syndrome can be made before or after birth, using various methods such as ultrasound screening, maternal blood tests, amniocentesis, chorionic villus sampling, or karyotyping. The treatment of Down syndrome involves a multidisciplinary approach that includes medical care, early intervention programs, special education, speech therapy, occupational therapy, physical therapy, and social support. The life expectancy of people with Down syndrome has improved significantly over the years, reaching an average of 60 years.

Trisomy 18 (Edwards syndrome) affects about 1 in 5,000 live births. It is caused by the presence of an extra copy of chromosome 18, which contains about 300 genes. People with Edwards syndrome have severe physical and mental abnormalities that are often life-threatening. They have distinctive facial features, such as a small head (microcephaly), a prominent occiput (back of the head), low-set ears, a small jaw (micrognathia), and clenched fists with overlapping fingers. They also have various organ malformations, such as heart defects, kidney problems, diaphragmatic hernia (a hole in the diaphragm), omphalocele (a protrusion of abdominal organs through the navel), and neural tube defects (spina bifida or anencephaly). Moreover, they have profound intellectual disabilities and developmental delays. The diagnosis of Edwards syndrome can be made before or after birth, using similar methods as for Down syndrome. The treatment of Edwards syndrome is mainly supportive and palliative, as there is no cure for this condition. The prognosis of people with Edwards syndrome is very poor, with only about 10% surviving beyond the first year of life.

Trisomy 13 (Patau syndrome) affects about 1 in 10,000 live births. It is caused by the presence of an extra copy of chromosome 13, which contains about 400 genes. People with Patau syndrome have severe physical and mental abnormalities that are often incompatible with life. They have distinctive facial features, such as a small head (microcephaly), cleft lip and palate (a split in the upper lip and roof of the mouth), small eyes (microphthalmia) or absent eyes (anophthalmia), low-set ears, and scalp defects. They also have various organ malformations, such as heart defects, brain anomalies (holoprosencephaly or cyclopia), kidney problems (polycystic kidney disease or renal agenesis), omphalocele (a protrusion of abdominal organs through the navel), and polydactyly (extra fingers or toes). Moreover, they have profound intellectual disabilities and developmental delays. The diagnosis of Patau syndrome can be made before or after birth, using similar methods as for Down syndrome. The treatment of Patau syndrome is mainly supportive and palliative, as there is no cure for this condition.

Turner Syndrome

Turner syndrome is a female-only genetic disorder that affects about 1 in every 2,000 to 5,000 baby girls. A girl with Turner syndrome only has one normal X chromosome instead of two. This chromosome variation happens randomly when the baby is conceived in the womb. It is not linked to the mother's age or any environmental factors. Turner syndrome can cause a variety of medical and developmental problems, including short height, failure of the ovaries to develop, and heart defects. Some physical features that may be present at birth or during infancy are a wide or weblike neck, low-set ears, a broad chest with widely spaced nipples, a high palate, arms that turn outward at the elbows, narrow fingernails and toenails that are turned upward, and swelling of the hands and feet. Most girls with Turner syndrome do not develop menstrual periods or breasts without hormone treatment and are unable to have children without reproductive technology. Some other possible problems are diabetes, low thyroid hormone levels, vision and hearing impairments, and learning difficulties, especially in mathematics and spatial visualization.

Turner syndrome may be suspected before birth based on prenatal cell-free DNA screening or ultrasound findings such as a large fluid collection on the back of the neck or other abnormal fluid collections (edema), heart abnormalities, or abnormal kidneys. After birth or during childhood, the diagnosis may be based on physical signs such as short stature or delayed puberty. In some cases, the diagnosis may be delayed until adolescence or adulthood, when menstrual irregularities or infertility prompt further investigation. Genetic testing such as karyotype analysis (examining the chromosomes under a microscope), fluorescent in situ hybridization (FISH) (using fluorescent probes to detect specific regions on the chromosomes), or gene chip (using microarrays to detect copy number variations on the chromosomes) can confirm the presence of one X chromosome or a part of it that is missing.

There is no cure for Turner syndrome, but treatments can help improve the quality of life and health outcomes of people with this condition. Growth hormone therapy can help increase height if it is started early in childhood. Estrogen replacement therapy can help induce puberty and prevent osteoporosis (bone loss). Heart surgery can correct some congenital heart defects, such as narrowing of the aorta (the main artery that carries blood from the heart) or leakage of the aortic valve (the valve that controls blood flow from the heart to the aorta). Endocrine therapy can help regulate blood sugar levels for people with diabetes or thyroid hormone levels for people with hypothyroidism (low thyroid function). Assisted reproductive technology, such as in vitro fertilization (IVF) using donated eggs, can help women with Turner syndrome achieve pregnancy and childbirth. The prognosis of Turner syndrome varies depending on the severity of symptoms and complications and the effectiveness of treatment. People with Turner syndrome have a shorter life expectancy than average, mainly due to an increased risk of cardiovascular diseases such as heart failure and stroke and endocrine disorders such as diabetes. However, regular medical care and follow-up can help prevent or manage these conditions and improve survival rates. People with Turner syndrome can also lead healthy, independent, and fulfilling lives with proper education, support, and counseling.

Klinefelter Syndrome

Klinefelter syndrome is a genetic condition in which males have an extra X chromosome. It is not inherited, but caused by a random genetic error during the formation or fertilization of the egg or sperm. Klinefelter syndrome affects males differently, depending on the number and location of the extra X chromosomes. Some common symptoms include small penis and testes, low testosterone levels, infertility, breast enlargement, tall stature, learning and behavioral difficulties, and emotional problems. Klinefelter syndrome can be diagnosed by blood tests (to check the chromosome pattern and hormone levels), semen analysis (to check the sperm count and quality), and ultrasound (to check the testes size and structure).

Klinefelter syndrome can be detected by genetic testing, either before or after birth. Genetic testing can help patients and their families understand their condition and prepare for appropriate interventions. However, there is no effective gene therapy for Klinefelter syndrome yet. Gene therapy would require the precise deletion of the extra X chromosome without affecting other normal genes. This is a very complex and difficult technical challenge that needs more scientific research and clinical trials to verify its safety and efficacy. Klinefelter syndrome has no cure, but some treatments can improve the quality of life and health of the patients. These include testosterone replacement therapy (to boost male characteristics, mood, and sexual function), surgery (to remove excess breast tissue or abnormal tissue in the testes), assisted reproductive techniques (to use the few sperm extracted from the testes for artificial insemination or in vitro fertilization), and psychological counseling (to help the patients build self-confidence, cope with stress, and solve social or emotional issues).

References

1. Krivega M, et al. Consequences of chromosome gain: A new view on trisomy syndromes. Am J Hum Genet. 2022 Dec 1;109(12):2126-2140.
2. Krivega M, et al. Consequences of trisomy syndromes - 21 and beyond. Trends Genet. 2023 Mar;39(3):172-174.
3. Carey JC. Survival Outcomes of Infants with the Trisomy 13 or Trisomy 18 Syndromes. J Pediatr. 2022 Aug;247:11-13.
4. Zhang H, et al. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. Ultrasound Obstet Gynecol. 2015 May;45(5):530-8.
5. Gravholt CH, et al. Turner syndrome: mechanisms and management. Nat Rev Endocrinol. 2019 Oct;15(10):601-614.
6. Gravholt CH, et al; International Turner Syndrome Consensus Group. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017 Sep;177(3):G1-G70.
7. Aly J, et al. Novel insights in Turner syndrome. Curr Opin Pediatr. 2022 Aug 1;34(4):447-460.
8. Viuff M, et al. Epigenetics and genomics in Turner syndrome. Am J Med Genet C Semin Med Genet. 2019 Mar;181(1):68-75.
9. Bonomi M, et al. Klinefelter syndrome (KS): genetics, clinical phenotype and hypogonadism. J Endocrinol Invest. 2017 Feb;40(2):123-134.
10. Bearelly P, et al. Recent advances in managing and understanding Klinefelter syndrome. F1000Res. 2019 Jan 28;8:F1000 Faculty Rev-112.
11. Gravholt CH, et al. Klinefelter Syndrome: Integrating Genetics, Neuropsychology, and Endocrinology. Endocr Rev. 2018 Aug 1;39(4):389-423.
12. Chang S, et al. Klinefelter Syndrome and medical treatment: hypogonadism and beyond. Hormones (Athens). 2015 Oct-Dec;14(4):531-48.